Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;7(1):59.
doi: 10.1186/s41100-021-00378-0. Epub 2021 Oct 21.

Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study

Kan Kikuchi  1 , Masaomi Nangaku  2 , Munekazu Ryuzaki  3 , Tomoyuki Yamakawa  4 , Oota Yoshihiro  5 , Norio Hanafusa  6 , Ken Sakai  7 , Yoshihiko Kanno  8 , Ryoichi Ando  9 , Toshio Shinoda  10 , Hidetomo Nakamoto  11 , Tadao Akizawa  12 ; COVID-19 Task Force Committee of the Japanese Association of Dialysis Physicians, the Japanese Society for Dialysis Therapy, and the Japanese Society of Nephrology
Affiliations

Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study

Kan Kikuchi et al. Ren Replace Ther. 2021.

Abstract

Background: The Japanese Association of Dialysis Physicians, the Japanese Society for Dialysis Therapy, and the Japanese Society of Nephrology jointly established COVID-19 Task Force Committee and began surveying the number of newly infected patients.

Methods: This registry of the COVID-19 Task Force Committee was used to collect data of dialysis patients; a total of 1010 dialysis patients with COVID-19 were included in the analysis. Overall survival of patients was investigated with stratification by age group, complication status, and treatment. In addition, predictive factors for mortality were also investigated. The overall survival was estimated by Kaplan-Meier methods and compared by using log-rank test. Multivariate analysis was performed to identify the risk factor of mortality. For all statistical analyses, p < 0.05 was considered to be statistically significant.

Results: The mortality risk was increased with age (p < 0.001). The mortality risk was significantly higher in patients with peripheral arterial disease (HR: 1.49, 95% CI 1.05-2.10) and significantly lower in patients who were treated with remdesivir (HR: 0.60, 95% CI 0.37-0.98). Multivariate analysis showed increased risk of mortality with increment in BMI, and increment in CRP, and decreased risk with increment in albumin.

Conclusion: Dialysis patients have a high severity of illness and a high risk of mortality in cases of COVID-19. Treatment with remdesivir might be effective in shortening the duration of hospitalization and reducing the risk of mortality.

Keywords: COVID-19; Dialysis; Peritoneal dialysis; Remdesivir; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Competing interestsNone.

Figures

Fig. 1
Fig. 1
Overall survival stratified by age groups (< 60, 60 s, and ≥ 70)
Fig. 2
Fig. 2
Overall survival stratified by administration of remdesivir (with or without remdesivir)
Fig. 3
Fig. 3
Overall survival stratified by dialysis treatment (peritoneal dialysis or hemodialysis)
See this image and copyright information in PMC

References

    1. World Health Organization (WHO). Coronavirus disease (COVID-19) Pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 14 Aug 2021.
    1. The Japanese Ministry of Health Labour and Welfare. Current status of COVID-19 in the general population in Japan (as of Aug 14, 2021). https://www.mhlw.go.jp/stf/newpage_20461.html. Accessed 14 Aug 2021. (in Japanese).
    1. Kikuchi K, Nangaku M, Ryuzaki M, Yamakawa T, Hanafusa N, Sakai K, et al. Current status and guidance on preventive measures. Ther Apher Dial. 2020;24(4):361–365. doi: 10.1111/1744-9987.13531. - DOI - PMC - PubMed
    1. Kikuchi K, Nangaku M, Ryuzaki M, Yamakawa T. COVID-19 task force committee of the Japanese association of dialysis physicians; the Japanese society for dialysis therapy; the Japanese society of nephrology cumulative number of COVID-19 in dialysis patients. https://jsn.or.jp/medic/data/COVID-19number-of-infected_20210813.pdf. Accessed 14 Aug 2021. (in Japanese).
    1. The Japanese Ministry of Health Labour and Welfare. Outbreak trends of COVID-19 in the general population in Japan (as of Aug 14, 2021). https://www.mhlw.go.jp/content/10906000/000793909.pdf. Accessed 14 Aug 2021. (in Japanese).

LinkOut - more resources